BMGL Stock Basel Medical Group (BMGL, $5.94) is a top weekly gainer for penny stocks, rising +20.39%
at Tickeron.com
Loading...
A.I.dvisor analyzed 49 other stocks in the Hospital/Nursing Management Industry over the last week and discovered that of them (5) exhibited an Uptrend while of them (4) exhibited a Downtrend.
BMGL's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for BMGL turned positive on September 11, 2026. Looking at past instances where BMGL's MACD turned positive, the stock continued to rise in 15 of 17 cases over the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BMGL's RSI Oscillator exited the oversold zone, 6 of 8 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMGL advanced for three days, in 48 of 58 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMGL as a result. In 35 of 37 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMGL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
BMGL broke above its upper Bollinger Band on August 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BMGL entered a downward trend on August 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. BMGL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.444) is normal, around the industry mean (238.721). P/E Ratio (155.240) is within average values for comparable stocks, (132.225). BMGL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.624). BMGL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.014). P/S Ratio (0.623) is also within normal values, averaging (2.673).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMGL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.